MicroRNAs (miRNAs), non-coding RNAs of 19--25 nucleotides, play critical roles in various cellular processes such as proliferation, differentiation, and cell viability. During inflammation, the expression of certain miRNAs is upregulated, and these miRNAs contribute to some inflammation-induced degenerative reactions. Among the inflammation-associated miRNAs identified, miR-155 is highly conserved one across vertebrate species and is thought to be one of the important miRNA involved in the inflammatory response. Pro-inflammatory signals, such as interleukin (IL)-1, IL-6, and tumor necrosis factor (TNF)-α upregulate the expression of miR-155. Recently, it has been discovered that expression of miR-155 is increased in some chronic CNS disorders \[[@r1]\]. Furthermore, inhibiting miR-155 activity with complementary anti-miRNA oligonucleotides reduces impairment in animal models of CNS disorders. Moreover, in aged individuals \[[@r2]\] and tissues \[[@r3]\], upregulation of miR-155 expression is demonstrated. Since chronic inflammation is often associated with normal and pathological aging \[[@r4]\], the idea that miR-155 expression is activated in aged tissues and involves in tissue degeneration is reasonable.

In the inflammatory condition, stem cells are excessively activated or/and accumulate cytotoxic molecules such as reactive oxygen species (ROS). These actions could lead to depletion of the stem cell pool and, as a result, induce tissue degeneration \[[@r5]\]. In the recent studies, it has been reported that miR-155 is responsible for both induction of differentiation \[[@r1]\] and generation of ROS in the somatic stem cells \[[@r3]\]. In the neural stem cells (NSCs), overexpression of miR-155 resulted in disruption of stem cell self-renewal-associated genes *Musashi1*, *Hes1*, and *Bmi1*. The miR-155 expressing NSCs failed to form neurospheres, and their proliferation was reduced. On the contrary, inhibition of miR-155 suppressed IL-1-induced differentiation in the NSCs. Importantly, it has been shown that these reactions were conserved in human NSCs derived from induced pluripotent stem (iPS) cells \[[@r1]\].

On the other hand, accumulation of ROS is a well-known feature of aging and is the direct cause of stem cell degeneration. Since ROS can form a positive feedback loop with inflammatory cytokines, it is essential to find the critical mediator connecting inflammation and ROS generation in order to develop a way to manage it. In the recent paper, it has been demonstrated that miR-155 suppressed the anti-oxidant genes *Nfe2l2*, *Sod1*, and *Hmox1* and triggered ROS accumulation in the mesenchymal stem cells (MSCs). When miR-155 expression is suppressed, IL-1β induced ROS generation was moderated. Consistent with these notions, deletion of miR-155 genes by the CRISPR/Cas9 system brought about reduction of ROS levels in the MSCs *in vivo* \[[@r3]\]. Based on these results, an important hypothesis was proposed: miR-155 induce ROS generation by suppressing antioxidant gene expressions, which is the phenomenon observed in inflamed and/or aged tissues. The aforementioned two studies with NSCs and MSCs suggest that miR-155 is a responsible molecule for inflammation-associated stem cell dysfunction. A central question in these studies was how miR-155, just a single miRNA, regulated multiple genes involving different biological events. We hypothesized that miR-155 affects expression of these genes through targeting of a common master transcription factor(s). Analysis using public digital databases identified that a CCAAT/enhancer-binding protein, C/EBPβ, is one of the molecules mediating the miR-155-induced stem cell dysfunctions. Inhibition of C/EBPβ resulted in induction of differentiation in NSCs and ROS generation in MSCs. Furthermore, the expression level of C/EBPβ was strongly attenuated by miR-155. These observations provided the scheme of process connecting aging-associated inflammation and stem cell deteriorations: 1) inflammation activates miR-155 expression, 2) miR-155 blockades C/EBPβ expression, and 3) downregulation of C/EBPβ results in decreased expression of its downstream genes needed for antioxidation and stem cell self-renewal ([Figure 1](#f1){ref-type="fig"}).
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In the inflammatory condition, upregulated miR-155 activates stem cell differentiation, but expression of antioxidant-related genes is suppressed by miR-155. Thus, it is thought that excessive inflammation and miR-155 expression could be a risk for stem cell depletion and disturbance of tissue integrity.](aging-10-101374-g001){#f1}

Although we presumed that miR-155 is an inflammation-associated mediator in the above two studies, miR-155 expression could also be upregulated by hypoxic conditions or loss of its transcriptional repressors. Now, it has been shown that aging is a process accompanied by a general decrease in O~2~ supply in tissues \[[@r6]\]. Furthermore, it was also reported that expression of Notch1, which is a major repressor of miR-155 transcription, was significantly downregulated in aged mice \[[@r7]\]. These evidences show that aged tissue is a very supportive environment for miR-155 expression, and therefore miR-155 could be an important player for aging/inflammation-related stem cell deterioration. Now, miRNA therapy modulating pathogenic miRNA expression by antisense inhibition has become a promising option for the management of various diseases. Therapies using miR-155 inhibitors may provide novel strategies for managing various inflammation-associated diseases, aging, and their related stem cell depletion.
